Key result
Upf1 loss drives cardiac hypertrophy and post-MI pathogenesis by altering mRNA stability via RBFox1.
Population
Cultured normal and hypertrophic cardiomyocytes, and mouse models of myocardial infarction
Comparison
Manipulation of Upf1 expression vs Control/normal conditions
Design
Preclinical
Authors
Loading...
Upf1 and RBFox1 regulate a novel NMD-independent mRNA decay pathway during cardiac hypertrophy, presenting a potential therapeutic target for cardiac remodeling.
Upf1 and RBFox1 regulate a novel NMD-independent mRNA decay pathway during cardiac hypertrophy, presenting a potential therapeutic target for cardiac remodeling.
Song et al. (2025) studied Cardiac hypertrophy. Upf1 inactivation vs. Normal expression was evaluated on Cardiac hypertrophy and mRNA stability. Loss of Upf1 expression led to cardiac hypertrophy and exacerbated myocardial infarction-induced pathogenesis, identifying a global shift of mRNA stability regulated by the Upf1-RBFox1 complex.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: